Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma.
Trefzer
Uwe
U
Sterry
Wolfram
W
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000279:Administration, Cutaneous; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003521:Cyclopropanes / Q000008:administration & dosage*; D003606:Dacarbazine / Q000008:administration & dosage*; D019583:Dose Fractionation, Radiation; D005500:Follow-Up Studies; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary; D018714:Radiotherapy, Adjuvant; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D003521:Cyclopropanes; D003606:Dacarbazine; C029402:diphenylcyclopropenone